New study tracks side effects of leading lung cancer therapies in Real-World patients
NCT ID NCT07215962
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 26 times
Summary
This study observes 300 adults with advanced non-small cell lung cancer and low PD-L1 levels to see how safe and tolerable their first treatments are. Researchers track side effects, how often they happen, and what healthcare resources are used. The goal is to understand real-world outcomes for these patients, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER NSCLC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Florida Cancer Specialists & Research Institute
Fleming Island, Florida, 32003, United States
Conditions
Explore the condition pages connected to this study.